2026-01-22 - Analysis Report
**Market Update for Welltower (WELL)**

### Company Overview
Welltower is a real estate investment trust (REIT) that invests in healthcare-related properties, such as medical offices, outpatient surgery centers, and senior housing facilities.

### Return Rate Comparison
The cumulative return of Welltower is 122.12%, while the S&P 500 (VOO) has a cumulative return of 91.55%. The divergence between the two is 30.57%.

### Alpha and Beta Analysis

| Year | CAGR | MDD | Alpha | Beta | Cap (B) |
|------|------|-----|-------|------|---------|
| 2016-2018 | 14.0% | 15.3% | 9.0% | 0.5 | 47.6B |
| 2017-2019 | 24.0% | 15.3% | 7.0% | 0.3 | 56.1B |
| 2018-2020 | 39.0% | 30.5% | 18.0% | 1.1 | 44.4B |
| 2019-2021 | 19.0% | 30.5% | -25.0% | 1.3 | 58.9B |
| 2020-2022 | -15.0% | 34.0% | -13.0% | 1.1 | 45.0B |
| 2021-2023 | 6.0% | 34.0% | 5.0% | 0.7 | 61.9B |
| 2022-2024 | 29.0% | 34.0% | 10.0% | 0.6 | 86.5B |
| 2023-2025 | 98.0% | 12.4% | 36.0% | 0.5 | 127.4B |

### Stock Price Fluctuations
The 5-day SMA is $188.44, the 20-day SMA is $187.23, and the 60-day SMA is $190.77.

### Technical Indicators

* RSI: 44.84
* PPO: 0.18
* MRI: 0.80 (Medium Investment)
* Recent relative divergence change: +7.00 (Improving)
* 7-day Rank change: +15 (Rank up)
* 7-day Dynamic Expected Return change: +0.20 (Improving)
* Expected Return: -0.90%

### Recent Events

The most recent news articles for Welltower are:
* Vale Jumps After Trading Volume Surges Well Above Average
* Murphy Oil Stock (-10%): Civette Well Disappointment Derails Exploration Narrative
* Welltower Inc. $WELL Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH
* WELL Health: Whatâ€™s in Store for the Stock in 2026?
* Inside WELL Health's 2026 digital health growth plan from its CEO
* Murphy Oil Stock Plunges Nearly 9% After Civette Exploration Well Fails To Hit Commercial Threshold

### Analyst Opinions
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.65 (~Buy)
- Opinions: 20
- Target Price (avg/high/low): 209.70 / 260.00 / 162.00

### Earnings Analysis
| Date | EPS | Revenue |
|------|-----|---------|
| 2025-10-28 | 0.42 | $2.06B |
| 2025-07-29 | 0.46 | $1.97B |
| 2025-04-29 | 0.4 | $1.86B |
| 2024-10-29 | 0.74 | $1.51B |
| 2025-10-28 | 0.74 | $1.51B |

### Financial Information
**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.63B | 39.99% |
| 2025-06-30 | $2.52B | 39.80% |
| 2025-03-31 | $2.39B | 38.78% |
| 2024-12-31 | $2.22B | 36.50% |
| 2024-09-30 | $2.01B | 39.70% |

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $38.76B | 0.72% |
| 2025-06-30 | $35.90B | 0.84% |
| 2025-03-31 | $33.96B | 0.76% |
| 2024-12-31 | $31.96B | 0.38% |
| 2024-09-30 | $30.33B | 1.48% |

### Comprehensive Analysis
Welltower's cumulative return of 122.12% significantly outperforms the S&P 500's cumulative return of 91.55%, indicating a strong divergence of 30.57%. The company's recent stock price fluctuations are also notable, with a 5-day SMA of $188.44, a 20-day SMA of $187.23, and a 60-day SMA of $190.77. Technical indicators, such as the RSI and PPO, are currently bearish, but the MRI is still at a medium investment level. Recent news articles suggest that the company is experiencing some challenges, but analyst opinions remain generally positive. Finally, the company's financial information shows a decline in revenue and profit margin over the past year, but its equity and ROE have increased in the latest quarter.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.